Benzaoui, Mehdi

Publications

Sort by

Co-Author Network

Metabolic dialogues: regulators of chimeric antigen receptor T cell function in the tumor microenvironment. Molecular oncology. 2024 Information Resource GET IT
Times cited: 10
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output. Molecular therapy. Methods & clinical development. 2023 Academic Article GET IT
Times cited: 11
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma. The Journal of clinical investigation. 2022 Academic Article GET IT
Times cited: 56
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR. Blood. 2022 Academic Article GET IT
Times cited: 133
A SNIPpet of safety: a Goldilocks approach in CAR-T therapy. Cell research. 2022 Article GET IT
Times cited: 1
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy. Cancers. 2021 Academic Article GET IT
Times cited: 27

Sort by

Co-investigator Network

Targeting tumor and T-cell metabolism to bridge the gap in CAR-T efficacy between liquid and solid tumors awarded by Parker Institute for Cancer Immunotherapy Principal Investigator 2025 - 2026

Targeting immune evasion in gastroesophageal cancer awarded by Stand Up To Cancer Key Personnel 2023 - 2026